G-CSF regulation of SRE-binding proteins in myeloid cells
16, 2332-2333. doi:10.1038/sj.leu.2402686
TO THE EDITOR
The hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF) regulates myeloid progenitor cell proliferation, differentiation and survival. G-CSF mediates its effects through interaction with the G-CSF receptor (G-CSFR) which leads to activation of intracellular signaling pathways, including the Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT), ras/mitogen-activated protein kinase (MAPK), phosphatidylinositol (3)-kinase (PI3K)/AKT, and protein kinase C pathways (PKC). [1] [2] [3] The nuclear targets of most of these pathways have not been elucidated.
We previously demonstrated that the serum response element-1 (SRE-1) between nucleotides −418 and −391 of the egr-1 promoter is responsive to G-CSF in the myeloid leukemia cell line, NFS60. 4 The SRE-1 contains a central serum response element (SRE) and two adjacent ETS protein-binding sites (EBS). In electromobility shift assays, the serum response factor (SRF) binds constitutively to the CArG box of the SRE whereas the ETS protein Fli-1 binds the 5Ј Ets binding site (EBS). Furthermore, the SRE and EBSs of SRE-1 are each required for maximal transcriptional activation of a reporter construct containing a single copy of SRE-1 in response to G-CSF.
It has previously been shown that G-CSF stimulation of NFS60 cells activates RAS and the MAPK ERK1/2. 5 To determine if the MEK/ERK pathway is upstream of SRE-1 activation in response to G-CSF, NFS60 cells were transiently transfected with pTE2-SRE-1 or pTE2 and treated with the MEK 1 inhibitor, PD98059 prior to G-CSF stimulation. A dose-dependent decrease in pTE2-SRE-1 activity was observed at con- centrations between 0 and 50 M PD98059 (Figure 1a) . A two-fold decrease with PD98059 (50 M) was observed compared to DMSO control (P = 0.0332). No significant decrease in fold induction was found in pTE2-SRE-1 transfected cells treated with the p38 inhibitor SB203580 at 5 M or 10 M (data not shown). Transient transfections in NFS60 cells with DN ERK1, which contains a mutation in the ATP binding site, resulted in a 50% reduction in SRE-1CAT reporter activity (P = 0.0445) (Figure 1b) . Co-transfection with wild-type ERK1 showed no difference in SRE-1 transcription with G-CSF stimulation (data not shown). These results suggest that activation of SRE-1 in response to G-CSF occurs, at least in part, through a MEK1/ERK1-dependent pathway. PI3K and its downstream target AKT are activated in G-CSF stimu-lated BAF3 cells that are stably transfected with the G-CSF receptor. 2 To determine whether binding of G-CSF to endogenous G-CSF-R results in AKT activation, we performed Western blot analysis using phospho-AKT (Ser 473) antibody and NFS60 cell lysates pre-treated with or without 20 M PI3K inhibitor, LY294002. Our results demonstrated that AKT is phosphorylated at 5 and 15 min following G-CSF stimulation in the absence of LY294002 (Figure 1c) . However, activation of AKT in response to G-CSF is inhibited in the presence of LY294002 inhibitor (Figure 1c) . To test whether SRE-1 activation in response to G-CSF occurs through PI3 kinase, we stimulated cells with G-CSF and LY294002. We observed a statistically significant decrease in SRE-1 reporter activity (two-fold and 3.5-fold, respectively) at both 10 M and 20 M of LY294002 (P = 0.0214 and P = 0.008, respectively). These results suggest that the PI3K/AKT pathway also mediates activation of SRE-binding proteins in response to G-CSF stimulation. G-CSF stimulation of NFS60 cells results in activation of PKC in a protein tyrosine kinase-dependent manner.
3 PKC is also strongly activated upon stimulation with 12-O-tetradecanoylphorbol-13-ester (TPA), resulting in the induction of immediate-early genes, such as cfos and egr-1. 6, 7 To test whether PKC is an upstream mediator of SRE-1 transcription in response to G-CSF, we stimulated cells with the PKC inhibitor bisindolymaleimide. Bisindolymaleimide (1 M) did not inhibit SRE-1 reporter activity in cells treated with G-CSF (P = 0.2603) ( Figure  1d ). However, we observed a statistically significant decrease in the fold induction of the p-480 egr-1-CAT in response to TPA stimulation with the addition of 1 M bisindolymaleimide compared to DMSO control (P = 0.0412). Therefore, G-CSF activates SRE-1 transcription in a PKCindependent manner.
Our results demonstrate that G-CSF mediates transcription of SRE-1 in NFS60 cells through activation of MEK and PI3K pathways, which converge upon SRE-binding proteins. PKC has been shown to activate SRE-binding proteins in response to serum, TPA and growth factors. 7, 8 Our data suggest that PKC does not activate SRE-binding proteins in response to G-CSF, suggesting that there are cytokine-specific pathways that lead to activation of SRE-binding proteins in myeloid cells. Furthermore, our findings clarify previously described G-CSF-induced signal transduction pathways by linking them to the activation of the SRE-1 motif in a myeloid cell line that expresses endogenous G-CSF receptors. 
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Liver failure caused by reactivation of HBV is an infrequent complication after BMT, 1 although a few cases of fatal liver failure associated with HBV have been reported. 2 Recently, special attention has been paid to HBV precore mutant infection and fulminant hepatitis by HBV precore mutant has also been reported after BMT. 3, 4 We report here, an adolescent case of MDS infected by HBV precore mutant that was safely treated with unrelated BMT (U-BMT).
A 16-year-old female was diagnosed with MDS in January 1993. On admission, the karyotype of BM cells was 47,XX,+8. She was treated with low-dose cytarabine + recombinant human granulocyte colony-stimulating factor. Her clinical course has been previously 
